1 Jun 2021 15:01
1 June 2021 15:01 BST
Â
Â
BLOCK LISTING SIX MONTHLY RETURN
Â
Information provided on this form must be typed or printed electronically and provided to an ris.
Â
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Â
Date: 1 June 2021
Â
Name of applicant: | ASTRAZENECA PLC | |||
Name of scheme: | ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS-RELATED SHARE OPTION PLAN; ASTRAZENECA ALL-EMPLOYEE SHARE PLAN; ASTRAZENECA PLC 2012 SAVINGS-RELATED SHARE OPTION SCHEME | |||
Period of return: | From: | 1 DECEMBER 2020 | To: | 31 MAY 2021 |
Balance of unallotted securities under scheme(s) from previous return: | 709,452 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 5,000,000 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 456,674 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,252,778 | |||
Â
Name of contact: | HANNAH TATTERSALL |
Telephone number of contact: | +44 (0)746 498 2582 |
Â
Â
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Â
Â
Adrian KempCompany Secretary
AstraZeneca PLC
Â